Sermorelin affects growth hormone signaling. The former Geref products had specific pediatric growth hormone deficiency and diagnostic uses. FDA determined that their discontinuation was not for safety or effectiveness reasons. That history is not approval of compounded sermorelin or an anti-aging indication.
Compounded sermorelin is not FDA-approved and has not undergone FDA premarket review for safety, effectiveness and quality. Growth hormone signaling alone does not establish improved energy, muscle, recovery or longevity in otherwise healthy adults. Eligibility and lawful compounding require assessment of the exact preparation and circumstances.
Before considering any hormone-related intervention, a licensed clinician should assess the reason for symptoms and whether an established diagnosis is present. Fatigue and changes in strength or sleep can have many causes.
Discuss uncertainty in human evidence, possible adverse effects and interactions, contraindications and monitoring. There is no guaranteed before-and-after result or treatment timeline. This educational page is not a recommendation to obtain an unapproved product and does not provide dosing or purchasing instructions.
A responsible decision compares the exact proposed product with established options for the diagnosed condition. Ask who would prescribe it, which pharmacy would dispense it and what follow-up would be needed.